Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Feb 17;12(1):2763.
doi: 10.1038/s41598-022-06663-0.

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism

Affiliations
Meta-Analysis

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism

Paraskevi-Evita Papathoma et al. Sci Rep. .

Abstract

Differential diagnosis of parkinsonism early upon symptom onset is often challenging for clinicians and stressful for patients. Several neuroimaging methods have been previously evaluated; however specific routines remain to be established. The aim of this study was to systematically assess the diagnostic accuracy of a previously developed 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) based automated algorithm in the diagnosis of parkinsonian syndromes, including unpublished data from a prospective cohort. A series of 35 patients prospectively recruited in a movement disorder clinic in Stockholm were assessed, followed by systematic literature review and meta-analysis. In our cohort, automated image-based classification method showed excellent sensitivity and specificity for Parkinson Disease (PD) vs. atypical parkinsonian syndromes (APS), in line with the results of the meta-analysis (pooled sensitivity and specificity 0.84; 95% CI 0.79-0.88 and 0.96; 95% CI 0.91 -0.98, respectively). In conclusion, FDG-PET automated analysis has an excellent potential to distinguish between PD and APS early in the disease course and may be a valuable tool in clinical routine as well as in research applications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Assessment of risk of bias and concerns regarding applicability of the included studies using the Quality Assessment of Diagnostic Accuracy Studies Tool 2.
Figure 2
Figure 2
Flowchart of the successive steps of the systematic review process.
Figure 3
Figure 3
Forest plot of the included studies presenting sensitivity and specificity of each study along with the combined measures—first level of classification model, PD vs APS.
Figure 4
Figure 4
Level-1 classification algorithm for PD: Summary ROC plot with mean operating sensitivity and specificity point.
Figure 5
Figure 5
Level-2 classification algorithm for MSA: Summary ROC plot with mean operating sensitivity and specificity point.
Figure 6
Figure 6
Level-2 classification algorithm for PSP: Summary ROC plot with mean operating sensitivity and specificity point.

References

    1. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020;323:548–560. doi: 10.1001/jama.2019.22360. - DOI - PubMed
    1. Armstrong MJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503. doi: 10.1212/WNL.0b013e31827f0fd1. - DOI - PMC - PubMed
    1. Gilman S, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–676. doi: 10.1212/01.wnl.0000324625.00404.15. - DOI - PMC - PubMed
    1. Höglinger GU, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 2017;32:853–864. doi: 10.1002/mds.26987. - DOI - PMC - PubMed
    1. Postuma RB, et al. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord. 2018;33:1601–1608. doi: 10.1002/mds.27362. - DOI - PubMed

Publication types

MeSH terms